Company Filing History:
Years Active: 2013
Title: Adrienne Hoeglund: Innovator in Autotaxin Inhibition
Introduction
Adrienne Hoeglund is a notable inventor based in Collierville, TN (US). She has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit autotaxin enzymes. Her work has the potential to impact cancer treatment and prevention.
Latest Patents
Adrienne holds a patent for "Pipemidic acid derivative autotaxin inhibitors." This invention presents novel and optimized classes of pipemidic acid derivative compounds that effectively inhibit autotaxin enzymes. These compounds react with autotaxin to reduce the size of reactive sites, preventing the conversion of lysophosphatidyl choline to lysophosphatidic acid. Furthermore, these compounds can be incorporated into delivery forms for human ingestion, offering a promising approach to potentially reduce the generation of certain cancers linked to naturally occurring autotaxin in the human body. The methods of inactivating autotaxin to varying degrees are also encompassed within her invention.
Career Highlights
Adrienne is affiliated with the University of Memphis Research Foundation, where she continues her research and development efforts. Her innovative work in the field of autotaxin inhibition showcases her dedication to advancing medical science and improving health outcomes.
Collaborations
She collaborates with esteemed colleagues, including Abby Louise Parrill-Baker and Daniel Lee Baker, who contribute to her research endeavors.
Conclusion
Adrienne Hoeglund's contributions to the field of autotaxin inhibition represent a significant advancement in medical research. Her innovative compounds hold promise for cancer prevention and treatment, highlighting her role as a leading inventor in this critical area of study.